Shandong Keyuan Pharmaceutical Co., Ltd.

SZSE:301281 Stock Report

Market Cap: CN¥3.0b

Shandong Keyuan Pharmaceutical Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Jianwei Wang

Chief executive officer

CN¥427.1k

Total compensation

CEO salary percentagen/a
CEO tenure2.3yrs
CEO ownershipn/a
Management average tenureno data
Board average tenure1.2yrs

Recent management updates

Recent updates

More Unpleasant Surprises Could Be In Store For Shandong Keyuan Pharmaceutical Co., Ltd.'s (SZSE:301281) Shares After Tumbling 27%

Apr 18
More Unpleasant Surprises Could Be In Store For Shandong Keyuan Pharmaceutical Co., Ltd.'s (SZSE:301281) Shares After Tumbling 27%

Shandong Keyuan Pharmaceutical's (SZSE:301281) Weak Earnings May Only Reveal A Part Of The Whole Picture

Apr 08
Shandong Keyuan Pharmaceutical's (SZSE:301281) Weak Earnings May Only Reveal A Part Of The Whole Picture

CEO

Jianwei Wang (40 yo)

2.3yrs

Tenure

CN¥427,100

Compensation


Board Members

NamePositionTenureCompensationOwnership
Yi Ma
Non-Employee Supervisorless than a yearno datano data
Bin Wu
Non-Independent Director1.2yrsCN¥17.00kno data
Haiying Zheng
Independent Director5.8yrsCN¥100.00kno data
Yongbo Ge
Independent Director5.8yrsCN¥100.00kno data
Kang Yuan
Independent Director4yrsCN¥100.00kno data
Xiaohong Zou
Non-Independent Vice Chairman9.3yrsno datano data
Hongsheng Jiang
Non-Independent Chairman of the Board1.7yrsno datano data
Huiyu Dai
Independent Directorless than a yearno datano data
Dawei Zeng
Non-Employee Supervisorless than a yearno datano data
Yuankun Gao
Non-Independent Directorless than a yearno datano data
Lina Jin
Independent Directorless than a yearno datano data

1.2yrs

Average Tenure

58.5yo

Average Age

Experienced Board: 301281's board of directors are not considered experienced ( 1.2 years average tenure), which suggests a new board.


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/11 20:13
End of Day Share Price 2025/01/10 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Shandong Keyuan Pharmaceutical Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution